ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,123Medicare Part D Prescriptions Filled, Including Refills

Rank: 119 out of 1269

$525K Total Retail Price of All Prescriptions

Rank: 137 out of 1269

363 Patients Receiving at Least One Drug in Part D
77%Patients 65 Years and Older
72% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Maryland
Lower avg

Schedule Two
Controlled Substances

10% of this provider’s 363 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

5% of this provider’s 363 patients filled at least one prescription for a schedule three drug, compared to an average of 5%.

Risky Drugs to Seniors

1% of this provider’s 6,183 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

28% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$65 was the average price of a prescription from this provider, compared to $69 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Maryland
SIMVASTATIN 373 297 1 3
LISINOPRIL 312 202 2 1
AMLODIPINE BESYLATE 308 256 3 2
FUROSEMIDE 266 227 4 5
METOPROLOL TARTRATE 228 178 5 6
WARFARIN SODIUM 149 115 6 12
OMEPRAZOLE 145 127 7 8
ATORVASTATIN CALCIUM 141 116 8 7
LEVOTHYROXINE SODIUM 137 113 9 4
METFORMIN HCL 129 77 10 9
LOSARTAN POTASSIUM 115 83 11 15
NAMENDA 111 99 12 38
NIFEDIPINE ER 111 100 12 65
KLOR-CON 10 102 70 14 122
DIOVAN 99 81 15 35
HYDROCHLOROTHIAZIDE 99 71 15 10
CARVEDILOL 97 80 17 29
DONEPEZIL HCL 95 89 18 22
METOPROLOL SUCCINATE 92 85 19 13
GABAPENTIN 91 52 20 17
TRAMADOL HCL 90 69 21 16
SERTRALINE HCL 85 67 22 23
CLONIDINE HCL 84 55 23 51
CITALOPRAM HBR 84 55 23 21
POTASSIUM CHLORIDE 83 60 25 26
HYDRALAZINE HCL 77 57 26 48
RANITIDINE HCL 76 59 27 27
LEVETIRACETAM 76 52 27 55
QUETIAPINE FUMARATE 70 42 29 53
OXCARBAZEPINE 67 55 30 213
TAMSULOSIN HCL 63 63 31 31
BACLOFEN 62 0 32 103
DIGOXIN 61 42 33 62
TRAZODONE HCL 59 56 34 36
PANTOPRAZOLE SODIUM 58 53 35 18
ZOLPIDEM TARTRATE 58 39 35 19
CLOPIDOGREL 57 40 37 32
AZITHROMYCIN 57 46 37 42
PLAVIX 56 38 39 47
CRESTOR 55 51 40 25
DIVALPROEX SODIUM ER 55 43 40 176
ESCITALOPRAM OXALATE 55 36 40 58
DIVALPROEX SODIUM 54 0 43 54
LISINOPRIL-HYDROCHLOROTHIAZIDE 54 51 43 33
DIOVAN HCT 54 39 43 76
OXYCODONE-ACETAMINOPHEN 54 49 S2 43 44
GLIPIZIDE 53 34 47 37
LANTUS 52 37 48 39
ALLOPURINOL 51 42 49 49
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 2, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.